Author(s):
Endang Sunariyanti, Tri Murti Andayani, Dwi Endarti, Diah Ayu Puspandari
Email(s):
trimurtia@ugm.ac.id
DOI:
10.52711/0974-360X.2023.00293 
Address:
Endang Sunariyanti1, Tri Murti Andayani2, Dwi Endarti2, Diah Ayu Puspandari3
1Doctoral Program in Pharmaceutical Science, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.
2University of Muhammadiyah ar Fachruddin, Faculty of Pharmacy, Tangerang, Indonesia.
3Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia.
4Department ofPharmaceutics, Faculty of Pharmacy,Gadjah Mada University, Yogyakarta, Indonesia.
5Department of of Health Policy and Management, Faculty of Medicine, Public Health, and Nursing Universitas Gadjah Mada, Yogyakarta, Indonesia.
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2023
ABSTRACT:
Impaired kidney function is one of the main public health problems in Indonesia. In the era of National Health Insurance (JKN) health financing at Advanced Level Referral Facilities (FKRTL) used the Indonesian Case Based Group (INA-CBGs) rate, but hospital costs were often higher than the costs of INA-CBGs. This study aims to determine the difference in costs. in real terms with INA-CBGs rates for hospitalization in Indonesia. This study used a cross-sectional analytic study design with a hospital perspective. Collecting data using a retrospective method with data collection in the form of medical records of patients with chronic kidney failure on hemodialysis and data on patient treatment costs. The study was conducted in regional I and regional III, each region represented by class A, B, and private hospitals so that a total of 6 hospitals were involved in this study. The data is presented descriptively. The difference between the real cost and the cost of INA-CBGs using the Mann-Whitney test SPSS analysis. The results showed that the average real cost in class A hospitals was higher than the average real cost in class B and private class hospitals. Of the 6 hospitals studied, 5 hospitals showed that the total real cost for treating chronic kidney disease in Indonesia was still higher than the INA-CBGs rates. The highest average real cost for hospitals in regional 1 is in class A hospitals with a value of up to Rp. 13,709,812 per patient/year, these costs are in accordance with the INA-CBGs rates. Meanwhile in regional 3, the highest average real cost of Rp. 33,000,450 patients/year is in a class A hospital. This cost is much higher than the INA-CBGs rate. The results of statistical tests showed that there was a significant difference between the average real cost and the INA-CBGs tariff (p=0.000). The total difference caused is Rp. 13,851,798 so that it becomes a loss and a burden for the hospital.
Cite this article:
Endang Sunariyanti, Tri Murti Andayani, Dwi Endarti, Diah Ayu Puspandari. Cost Analysis of Therapy of Chronic Kidney Disease Inpatient In Indonesia. Research Journal of Pharmacy and Technology 2023; 16(4):1781-9. doi: 10.52711/0974-360X.2023.00293
Cite(Electronic):
Endang Sunariyanti, Tri Murti Andayani, Dwi Endarti, Diah Ayu Puspandari. Cost Analysis of Therapy of Chronic Kidney Disease Inpatient In Indonesia. Research Journal of Pharmacy and Technology 2023; 16(4):1781-9. doi: 10.52711/0974-360X.2023.00293 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-4-41
REFERENCES:
1. Rohenti IR, Rahmadaniati HU, Sarnianto P. Analisis Biaya Medis Langsung Pasien Hemodialisa di Rumah Sakit X Wilayah Bekasi. Pharm J Farm Indones (Pharmaceutical J Indones. 2019;16(2):386.
2. Nurwanti R. Analisis Biaya Pengobatan Gagal Ginjal Kronik dengan Hemodialisis pada Pasien Rawat Inap di RSD Dr. Soebandi Jember Periode 2009. Pharmauho J Farm Sains, dan Kesehat. 2018;4(1):42–7.
3. Advistasari YD, Saputra WC, Sulistiyanto FX, Munisih S, Tinggi S, Farmasi I, et al. Cost Of Illness Perawatan Pasien Gagal Ginjal KronikDi Instalasi Rawat Inap Rsi Sultan Agung Semarang | Cost Of Illness Perawatan Pasien Gagal Ginjal Kronik Di Instalasi Rawat Inap Rsi Sultan Agung Semarang Cost Of Illness Of Patients With Chronic Kidney Failure Treatment At The Inpatient Installation Of Sultan Agung Islamic Hospital, Semarang.
4. Suryaman Prana Putra R, Jafar N. Ability to Pay and Catastrophic Payment on Self Payers Participants in BPJS Kesehatan Makassar. 2014;4(3):283–90.
5. Azalea M, Andayani TM. Inap Dengan Hemodialisis Di Rumah Sakit Cost Analysis Of Inpatient Hemodialysis In The Treatment Of Chronic. 2016;141–50.
6. Utami YT, Fanny N. Faktor Penyebab perbedaan selisih klaim negatif tarif INA-CBGs dengan biaya rill di RSUD Moewardi. Jurnal Sains dan Kesehatan. 3(3):492–9.
7. Fitri Y, Ali M, Sudjaswadhi. Analisis Biaya Perawatan Gagal Ginjal Kronis Rawat Inap Sebagai Pertimbangan Dalam Penetapan Pembiayaan Kesehatan Berdasar Ina-Drg Di Rsud Dr Moewardi. J Manaj Dan Pelayanan Farm. 2011;1(No.2).
8. Andi Ahriansyah, Sarnianto P, Anggriani Y. Analisis profil pengobatan, biaya medis dan kualitas hidup pada pasien hemodialisis poli rawat jalan di rumah sakit dr h. marzoeki mahdi bogor. 2019;6(1).
9. Dumaris H. Analisis Perbedaan Tarif Rumah Sakit dan Tarif INA-CBG ’ s Pelayanan Rawat Jalan di RSUD Budhi Asih Jakarta Tahun 2015 Analysis on Tariff Differences Between Hospital ’ s Tariff and INA - CBG ’ s Tariff for Outpatient In Budi Asih Hospital Jakarta on 2015. J ARSI. 2015;3:20–8.
10. Yani DA, Sarnianto P, Anggriani Y. Biaya Medis Langsung Pasien Hemodialisis Di Rumah Sakit Umum Daerah ( Rsud ) Arjawinangun Dan Rsud Waled Kabupaten Cirebon. Med Sains. 2019;4(1):51–60.
11. Rahayuningrum IO, Tamtomo D, suryono A. Comparison Between Hospital Inpatient Cost and INA-CBGs Tariff of Inpatient Care in the National Health Insurance Scheme in Solo, Boyolali and Karanganyar Districts, Central Java. J Heal Policy Manag. 2016;01(02):102–12.
12. Gigin bian rosmila, Rizal Yaya, Firman Pribadi. The comparison of the unit cost of hemodialysis with ina cbg rates in Muhammadiyah Siti Aminah Hospital. Arch Bus Res. 2020;8(5):80–95.
13. JamkesIndonesia D. Analisis Perbandingan Antara Biaya Pelayanan Pasien Rawat Jalan Dan Rawat Inap Berdasarkan Tarif Rum. 2014;
14. Mardhatillah, Tamtomo DG, Murti B. Factors Influencing the Difference between Indonesian Case-Based Group Reimbursement and Medical Cost for Patients with Chronic Renal Disease Cases in Kasih Ibu Hospital, Surakarta. J Heal Policy Manag [Internet]. 2017;02(02):117–27.
15. Monica RD, Mawar F, Suryati Y, Pujilestari I, Rohmayani D, Hendrati A. Analisis Perbedaan Tarif Riil Rumah Sakit dengan Tarif INA-CBG’s Berdasarkan Kelengkapan Medis Pasien Rawat Inap Pada Kasus Persalinan Sectio Caesarea Guna Pengendalian Biaya Rumah Sakit TNI AU Dr. M. Salamun Bandung. Jmiki [Internet]. 2021;9(1):90–6. Available from: https://jmiki.aptirmik.or.id/index.php/jmiki/article/view/90
16. Yuniarti E, Murti Handayani T. Analsis Biaya Terapi Penyakit Diabetes Melitus Pasien Jaminan Kesehatan Nasional Di Rs Pku Muhammadiyah Yogyakarta-Perbandingan Terhadap Tarif Ina Cbgs Cost Analysis Of Diabetes Mellitus Patients In The National Health Insurance At Pku Muhammadiyah Hospital-Comparison With Ina Cbgs Rates. Vol. 04, Jurnal Kebijakan Kesehatan Indonesia. 2015.
17. Tandah MR, Ihwan I, Diana K, Zulfiah Z, Ambianti N. Analisis Biaya Pengobatan Penyakit Ginjal Kronik Rawat Inap Dengan Hemodialisis Di Rumah Sakit Umum Daerah Undata Palu. Link. 2019;15(2):1–7.
18. Budiarto W, Sugiharto Dm. Biaya Klaim Ina Cbg S Dan Biaya Riil Penyakit Katastropik Rawat Inap Peserta Jamkesmas Di Rumah Sakit Studi Di 10 Rumah Sakit Milik Kementerian Kesehatan Januari-Maret 2012 (Expense of INA CBG S Claim and Real Expense of Catastropic Diseases Inpatient Jamkesmas Participant at Hospital Study in 10 Ministry of.
19. Tania F, Thabrany H. Biaya dan Outcome Hemodialisis di Rumah Sakit Kelas B dan C. J Ekon Kesehat Indones. 2017;1(1).